Resistance to diet-induced obesity in μ-opioid receptor-deficient mice: Evidence for a "thrifty gene"

Diabetes

Volumn 54, Issue 12, 2005, Pages 3510-3516

  Tabarin, Antoine ^a,b   Chaves, Yolanda Diz ^a   Carmona, Maria Del Carmen ^c   Catargi, Bogdan ^a,b   Zorrilla, Eric P ^b   Roberts, Amanda J ^b   Coscina, Donald V ^d   Rousset, Sophie ^e   Redonnet, Anabelle ^a   Parker, Graham C ^d   Inoue, Koki ^b   Ricquier, Daniel ^e   Pénicaud, Luc ^c   Kieffer, Brigitte L ^f   Koob, Georges F ^b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITÉ DE TOULOUSE   (France)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL ENZYME; MU OPIATE RECEPTOR; OPIATE RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; DIET; ENERGY METABOLISM; FAT INTAKE; FATTY ACID OXIDATION; FOOD INTAKE; HOMEOSTASIS; IMPAIRED GLUCOSE TOLERANCE; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SKELETAL MUSCLE;

EID: 33644688774     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/diabetes.54.12.3510     Document Type: Article

References (47)

1. Mansour A, Fox CA, Akil H, Watson SJ: Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18:22-29, 1995
2. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS: Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 20:68-100, 1999
3. Bodnar RJ: Endogenous opioids and feeding behavior: a 30-year historical perspective. Peptides 25:697-725, 2004
4. Kelley AE, Bakshi VP, Haber SN, Steininger TL, Will MJ, Zhang M: Opioid modulation of taste hedonics within the ventral striatum. Physiol Behav 76:365-377, 2002
5. Glass MJ, Billington CJ, Levine AS: Naltrexone administered to central nucleus of amygdala or PVN: neural dissociation of diet and energy. Am J Physiol 279:R86-R92, 2000
6. Mandenoff A, Fumeron F, Apfelbaum M, Margules DL: Endogenous opiates and energy balance. Science 215:1536-1538, 1982
7. Marks-Kaufman R, Balmagiya T, Gross E: Modifications in food intake and energy metabolism in rats as a function of chronic naltrexone infusions. Pharmacol Biochem Behav 20:911-916, 1984
8. Statnick MA, Tinsley FC, Eastwood BJ, Suter TM, Mitch CH, Heiman ML: Peptides that regulate food intake: antagonism of opioid receptors reduces body fat in obese rats by decreasing food intake and stimulating lipid utilization. Am J Physiol 284:R1399-R1408, 2003
9. Silva RM, Hadjimarkou MM, Rossi GC, Pasternak GW, Bodnar RJ: Beta-endorphin-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats. J Pharmacol Exp Ther 297:590-596, 2001
10. Brugman S, Clegg DJ, Woods SC, Seeley RJ: Combined blockade of both micro- and kappa-opioid receptors prevents the acute orexigenic action of Agouti-related protein. Endocrinology 143:4265-4270, 2002
11. Clegg DJ, Air EL, Woods SC, Seeley RJ: Eating elicited by orexin-a, but not melanin-concentrating hormone, is opioid mediated. Endocrinology 143:2995-3000, 2002
12. Hagan MM, Rushing PA, Benoit SC, Woods SC, Seeley RJ: Opioid receptor involvement in the effect of AgRP- (83-132) on food intake and food selection. Am J Physiol 280:R814-R821, 2001
13. Kotz CM, Grace MK, Billington CJ, Levine AS: The effect of norbinaltorphimine, beta-funaltrexamine and naltrindole on NPY-induced feeding. Brain Res 631:325-328, 1993
14. Gaveriaux-Ruff C, Kieffer BL: Opioid receptor genes inactivated in mice: the highlights. Neuropeptides 36:62-71, 2002
15. Neel JV: The "thrifty genotype" in 1998. Nutr Rev 57:S2-S9, 1999
16. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dolle P, Tzavara E, Hanoune J, Roques BP, Kieffer BL: Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383:819-823, 1996
17. Nagy TR, Clair AL: Precision and accuracy of dual-energy X-ray absorptiometry for determining in vivo body composition of mice. Obes Res 8:392-398, 2000
18. Parker GC, McKee ME, Bishop C, Coscina DV: Whole-body metabolism varies across the estrous cycle in Sprague-Dawley rats. Physiol Behav 74:399-403, 2001
19. Ricquier D, Barlet JP, Garel JM, Combes-George M, Dubois MP: An immunological study of the uncoupling protein of brown adipose tissue mitochondria. Biochem J 210:859-866, 1983
20. Froidevaux F, Schutz Y, Christin L, Jequier E: Energy expenditure in obese women before and during weight loss, after refeeding, and in the weight-relapse period. Am J Clin Nutr 57:35-42, 1993
21. Zurlo F, Lillioja S, Esposito-Del Puente A, Nyomba BL, Raz I, Saad MF, Swinburn BA, Knowler WC, Bogardus C, Ravussin E: Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol 259:E650-E657, 1990
22. Kahn BB, Flier JS: Obesity and insulin resistance. J Clin Invest 106:473-481, 2000
23. Buckingham JC, Cooper TA: Pharmacological characterization of opioid receptors influencing the secretion of corticotrophin releasing factor in the rat. Neuroendocrinology 44:36-40, 1986
24. Cole JL, Leventhal L, Pasternak GW, Bowen WD, Bodnar RJ: Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats. Brain Res 678:168-176, 1995
25. Appleyard SM, Hayward M, Young JI, Butler AA, Cone RD, Rubinstein M, Low MJ: A role for the endogenous opioid beta-endorphin in energy homeostasis. Endocrinology 144:1753-1760, 2003
26. Kas MJ, van den Bos R, Baars AM, Lubbers M, Lesscher HM, Hillebrand JJ, Schuller AG, Pintar JE, Spruijt BM: Mu-opioid receptor knockout mice show diminished food-anticipatory activity. Eur J Neurosci 20:1624-1632, 2004
27. Glass MJ, Billington CJ, Levine AS: Opioids and food intake: distributed functional neural pathways? Neuropeptides 33:360-368, 1999
28. Barsh GS, Schwartz MW: Genetic approaches to studying energy balance: perception and integration. Nat Rev Genet 3:589-600, 2002
29. Levac BA, O'Dowd BF, George SR: Oligomerization of opioid receptors: generation of novel signaling units. Curr Opin Pharmacol 2:76-81, 2002
30. Matthes HW, Smadja C, Valverde O, Vonesch JL, Foutz AS, Boudinot E, Denavit-Saubie M, Severini C, Negri L, Roques BP, Maldonado R, Kieffer BL: Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor. J Neurosci 18:7285-7295, 1998
31. Richter OM, Ludwig B: Cytochrome c oxidase: structure, function, and physiology of a redox-driven molecular machine. Rev Physiol Biochem Pharmacol 147:47-74, 2003
32. Liu X, Rossmeisl M, McClaine J, Riachi M, Harper ME, Kozak LP: Paradoxical resistance to diet-induced obesity in UCP1-deficient mice. J Clin Invest 111:399-407, 2003
33. Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, Zhou H, Fujimoto S, Oku A, Tsuda K, Toyokuni S, Hiai H, Mizunoya W, Fushiki T, Holst JJ, Makino M, Tashita A, Kobara Y, Tsubamoto Y, Jinnouchi T, Jomori T, Seino Y: Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 8:738-742, 2002
34. Surwit RS, Wang S, Petro AE, Sanchis D, Raimbault S, Ricquier D, Collins S: Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice. Proc Natl Acad Sci U S A 95:4061-4065, 1998
35. Wang S, Subramaniam A, Cawthorne MA, Clapham JC: Increased fatty acid oxidation in transgenic mice overexpressing UCP3 in skeletal muscle. Diabetes Obes Metab 5:295-301, 2003
36. Dobbins RL, Szczepaniak LS, Bentley B, Esser V, Myhill J, McGarry JD: Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. Diabetes 50:123-130, 2001
37. Kotz CM, Grace MK, Briggs J, Levine AS, Billington CJ: Effects of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat: neural site of action. J Clin Invest 96:163-170, 1995
38. Egawa M, Yoshimatsu H, Bray GA: Effect of beta-endorphin on sympathetic nerve activity to interscapular brown adipose tissue. Am J Physiol 264:R109-R115, 1993
39. Currie PJ, Coscina DV, Moretti J, Avellino MD: Paraventricular nucleus injections of naloxone methiodide inhibit NPY's effects on energy substrate utilization. Neuroreport 11:733-735, 2000
40. Obici S, Rossetti L: Minireview: nutrient sensing and the regulation of insulin action and energy balance. Endocrinology 144:5172-5178, 2003
41. Cheng JT, Liu IM, Chi TC, Tzeng TF, Lu FH, Chang CJ: Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats. Diabetes 50:2815-2821, 2001
42. Evans AA, Tunnicliffe G, Knights P, Bailey CJ, Smith ME: Delta opioid receptors mediate glucose uptake in skeletal muscles of lean and obese-diabetic (ob/ob) mice. Metabolism 50:1402-1408, 2001
43. Jaume M, Jacquet S, Cavailles P, Mace G, Stephan L, Blanpied C, Demur C, Brousset P, Dietrich G: Opioid receptor blockade reduces Fas-induced hepatitis in mice. Hepatology 40:1136-1143, 2004
44. Zimlichman R, Gefel D, Eliahou H, Matas Z, Rosen B, Gass S, Ela C, Eilam Y, Vogel Z, Barg J: Expression of opioid receptors during heart ontogeny in normotensive and hypertensive rats. Circulation 93:1020-1025, 1996
45. Yeomans MR, Gray RW: Opioid peptides and the control of human ingestive behaviour. Neurosci Biobehav Rev 26:713-728, 2002
46. Fruzzetti F, Bersi C, Parrini D, Ricci C, Genazzani AR: Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome. Fertil Steril 77:936-944, 2002
47. Smith SL, Harrold JA, Williams G: Diet-induced obesity increases mu opioid receptor binding in specific regions of the rat brain. Brain Res 953:215-222, 2002